Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Status epilepticus: the next decade.

I E Leppik1

  • 1Department of Neurology and Pharmacy, University of Minnesota, Minneapolis.

Neurology
|May 1, 1990
PubMed
Summary

Recent advances in treating status epilepticus (SE) have improved outcomes. However, current drugs have shortcomings, necessitating the development of novel treatment modalities for better patient prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory.

Epilepsy & behavior : E&B·2012
Same author

Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.

Journal of veterinary internal medicine·2012
Same author

Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.

Clinical pharmacology and therapeutics·2012
Same author

Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study.

Neurology·2010
Same author

Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy.

Neurology·2008
Same author

Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.

Journal of veterinary pharmacology and therapeutics·2008

Area of Science:

  • Neurology
  • Emergency Medicine
  • Pharmacology

Background:

  • Status epilepticus (SE) treatment has advanced, improving patient prognosis.
  • Mortality in SE is often linked to the underlying cause, not the seizures themselves.
  • Existing SE treatments have significant limitations.

Purpose of the Study:

  • To highlight the need for new treatment strategies for status epilepticus.
  • To address the shortcomings of current SE drug therapies.

Main Methods:

  • Literature review on SE treatment advancements.
  • Analysis of current therapeutic interventions and their limitations.

Main Results:

  • Prognosis for SE has improved due to recent therapeutic advances.
  • Current interventions can prevent seizure-related mortality.
  • Underlying disorders precipitate most SE-related deaths.

Conclusions:

  • Despite progress, current drugs for SE treatment have notable drawbacks.
  • Development of new treatment modalities for SE is crucial.
  • Addressing SE requires innovative therapeutic approaches.

Related Experiment Videos